Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Investing offers numerous advantages compared to saving, including potential for higher returns. Explore the benefits of making your money work for you.
12,774 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Can bloom energy stock going to $200 actually happen? This guide breaks down the catalysts, risks, and practical stra...
Meta reports rising engineering output amid a larger headcount, fueling a split between efficiency and payroll. The m...
Dollar General delivered strong Q4 numbers, yet the stock hasn’t taken off. This article breaks down what happened, w...
Former Indeed CEO Chris Hyams argues the real AI danger comes from the people steering the technology, not the code. ...
When a leading shipping stock leaps by a double-digit percentage, traders watch closely for what's driving the gains....
When a CEO disposes of stock, investors want context. This deep dive explains what fastly's sold company shares could...
Two months can change a market outlook dramatically. This piece breaks down why the idea of an opinion: stock market ...
When a CEO sells a sizable block of stock, investors take notice. This article breaks down the numbers behind imax so...
Abra aims to go public on Nasdaq through a SPAC valued at about $750 million. This move blends traditional markets wi...
Dell Technologies is pursuing aggressive AI data center growth, backed by a sizable backlog, while HP Inc. grapples w...
Regulators are examining capital rules that could allow banks to take a bigger share of mortgage lending. Banks say c...